Baillière's Clinical Haematology
Overview
Baillière's Clinical Haematology is a scientific journal, published since 1987 in English. The journal's country of origin is United Kingdom and its primary focus area is hematology.
Details
Details
Abbr.
Baillieres Clin Haematol
Start
1987
End
1998
Frequency
Four no. a year
p-ISSN
0950-3536
Country
United Kingdom
Language
English
Specialty
Hematology
Recent Articles
1.
Blau C
Baillieres Clin Haematol
. 2000 Jun;
11(1):257-75.
PMID: 10872481
Sickle cell anaemia and beta-thalassaemia are today curable through the use of stem cell transplantation. Nevertheless, the disadvantages inherent in stem cell transplantation underscore the need for better therapies. A...
2.
Rodgers G
Baillieres Clin Haematol
. 2000 Jun;
11(1):239-55.
PMID: 10872480
Collectively sickle cell disease and beta-thalassaemia are the most commonly inherited single-gene defects world-wide and were the first group of diseases for which DNA-based detection strategies were utilized. Although genotypically...
3.
Cao A, Galanello R, Rosatelli M
Baillieres Clin Haematol
. 2000 Jun;
11(1):215-38.
PMID: 10872479
This paper reviews the most important aspects of carrier detection procedures, genetic counselling, population screening and prenatal diagnosis of the thalassaemias and sickle cell anaemia. Carrier detection can be made...
4.
Ballas S
Baillieres Clin Haematol
. 2000 Jun;
11(1):185-214.
PMID: 10872478
Sickle cell syndromes are a group of inherited disorders of haemoglobin structure that have no cure in adults at the present time. Bone marrow transplantation in children has been shown...
5.
Steinberg M
Baillieres Clin Haematol
. 2000 Jun;
11(1):163-84.
PMID: 10872477
Sickle cell disease is caused by a mutation in the beta-globin chain of the haemoglobin molecule. Sickle haemoglobin, the result of this mutation, has the singular property of polymerizing when...
6.
Olivieri N
Baillieres Clin Haematol
. 2000 Jun;
11(1):147-62.
PMID: 10872476
Advances in the management of thalassaemia major have greatly improved the prognosis for patients with this disease. In countries able to afford programmes of regular transfusion and iron-chelating therapy, survival...
7.
Weatherall D
Baillieres Clin Haematol
. 2000 Jun;
11(1):127-46.
PMID: 10872475
Most of the major clinical manifestations of the beta-thalassaemias can be related to the deleterious effects of imbalanced globin chain synthesis on erythroid maturation and red cell survival. The destruction...
8.
Thein S
Baillieres Clin Haematol
. 2000 Jun;
11(1):91-126.
PMID: 10872474
A complete spectrum of genetic lesions affecting the beta-globin gene giving rise to a complete spectrum of phenotypic severity is described. Although most of the molecular lesions involve the structural...
9.
Bernini L, Harteveld C
Baillieres Clin Haematol
. 2000 Jun;
11(1):53-90.
PMID: 10872473
alpha-Thalassaemias are genetic defects extremely frequent in some populations and are characterized by the decrease or complete suppression of alpha-globin polypeptide chains. The gene cluster, which codes for and controls...
10.
Flint J, Harding R, Boyce A, Clegg J
Baillieres Clin Haematol
. 2000 Jun;
11(1):1-51.
PMID: 10872472
The haemoglobinopathies are the commonest single-gene disorders known, almost certainly because of the protection they provide against malaria, as attested by a number of observations. The geographical distributions of malaria...